[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Akro AKRO stock sees high social media engagement amidst buyout rumors, but mixed trial results and shrinking community size raise concerns. ### About Akro Akero Therapeutics (AKRO) is a biotechnology company focused on developing treatments for metabolic dysfunction-associated steatohepatitis (MASH). ### Insights [#](/topic/akro/insights) - akro sentiment is up XXXXX% from the previous week. ### Engagements: XXXXXX [#](/topic/akro/interactions) ---  [Engagements 24-Hour Chart Data](/topic/akro/time-series/interactions.tsv) **Current Value**: XXXXXX **Daily Average**: XXXXXX **1 Week**: XXXXXXX -XX% **1 Month**: XXXXXXXXX +33% **6 Months**: XXXXXXXXXX -XX% **1 Year**: XXXXXXXXXX -XXXX% **1-Year High**: XXXXXXX on 2025-01-12 **1-Year Low**: XXX on 2025-07-26 | Social Network | X | TikTok | YouTube | Reddit | News | | -------------- | - | ------ | ------- | ------ | ---- | | Engagements | XXXXXX | XXXXXX | XXXXXX | XXX | X | ### Mentions: XXX [#](/topic/akro/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/akro/time-series/posts_active.tsv) **Current Value**: XXX **Daily Average**: XXX **1 Week**: XXX +0.46% **1 Month**: XXXXX +55% **6 Months**: XXXXX -XX% **1 Year**: XXXXXX -XX% **1-Year High**: XXXXX on 2024-12-24 **1-Year Low**: XX on 2025-07-26 | Social Network | X | TikTok | YouTube | Reddit | News | | -------------- | - | ------ | ------- | ------ | ---- | | Mentions | XX | XX | XXX | XX | X | ### Creators: XXX [#](/topic/akro/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/akro/time-series/contributors_active.tsv) XXX unique social accounts have posts mentioning Akro in the last XX hours which is up XX% from XXX in the previous XX hours **Daily Average**: XXX **1 Week**: XXX -XXXX% **1 Month**: XXXXX +89% **6 Months**: XXXXX -XX% **1 Year**: XXXXX +15% **1-Year High**: XXX on 2024-12-24 **1-Year Low**: XX on 2025-07-26 The most influential creators that mention Akro in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@akro0059](/creator/tiktok/akro0059) | X | XXXXXX | X | XXXXX | | [@adelp](/creator/youtube/adelp) | X | X | X | XXXXX | | [@fatmab.aymaz](/creator/tiktok/fatmab.aymaz) | X | XXXXX | X | XXXXX | | [@leniiolaichomi10](/creator/youtube/leniiolaichomi10) | X | XX | X | XXX | | [@Biobeats99](/creator/twitter/Biobeats99) | X | XXX | X | XXX | [View More](/list/creators/akro/100) ### Sentiment: XX% [#](/topic/akro/sentiment) ---  [Sentiment 24-Hour Chart Data](/topic/akro/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% +13% **1 Month**: XX% -X% **6 Months**: XX% -X% **1 Year**: XX% -XX% **1-Year High**: XX% on 2024-09-14 **1-Year Low**: XX% on 2025-03-30 **Most Supportive Themes** - **Positive Sentiment and MASH Focus:** (63%) Positive sentiment is high, with XX% of mentions being positive, and the company's focus on MASH treatment is generating interest. - **High Social Media Engagement:** (35%) Mentions of AKRO are frequent across multiple social media platforms, with high engagement on TikTok and X. **Most Critical Themes** - **Mixed Trial Results:** (1%) Concerns about mixed results from the IMPACT trial of pemvidutide in MASH are being discussed. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXXX | XX% | XXXXX | XX% | XXX | X% | | TikTok | XXXXX | XX% | XXXXX | XX% | XXX | X% | | YouTube | XXXXX | X% | XXXXX | XX% | XXX | X% | | Reddit | XX | X% | XX | X% | XX | X% | | News | X | X% | X | X% | X | X% | | | | | | | | | | Total | XXXXXX | XX% | XXXXXX | XX% | XXXXX | X% | **Top assets mentioned** In the posts about Akro in the last XX hours [Akropolis (AKRO)](/topic/$akro) [Bitcoin Incognito (XBI)](/topic/$xbi) [Akero Therapeutics, Inc. Common Stock (AKRO)](/topic/akro-akero-therapeutics-inc) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Californium (CF)](/topic/$cf) [Eli Lilly and Company (LLY)](/topic/$lly) [Charles Schwab Corporation (SCHW)](/topic/$schw) [Swap (XWP)](/topic/$xwp) [Berry Global Group, Inc. (BERY)](/topic/$bery) [Akropolis (AKRO)](/topic/$akro-akropolis) **Top topics mentioned** In the posts about Akro in the last XX hours [#fyp](/topic/#fyp), [fragrance](/topic/fragrance), [coins sports](/topic/coins-sports), [vera](/topic/vera), [stocks technology](/topic/stocks-technology), [$abs](/topic/$abs), [wts](/topic/wts), [alt](/topic/alt), [ola](/topic/ola), [rklb](/topic/rklb), [$sndx](/topic/$sndx), [pltr](/topic/pltr), [#viral](/topic/#viral), [stocks](/topic/stocks), [dawn](/topic/dawn), [gme](/topic/gme), [par](/topic/par), [coins music](/topic/coins-music), [roma](/topic/roma), [coins healthcare](/topic/coins-healthcare), [$etnb](/topic/$etnb), [balance sheet](/topic/balance-sheet), [hims](/topic/hims), [whatsapp](/topic/whatsapp), [$xbi](/topic/$xbi), [amgn](/topic/amgn), [acquisition](/topic/acquisition), [rna](/topic/rna), [hood](/topic/hood), [nxt](/topic/nxt), [tiktok](/topic/tiktok), [foryoupage](/topic/foryoupage), [mbx](/topic/mbx), [instagram](/topic/instagram), [op](/topic/op), [$glpg](/topic/$glpg), [$qntm](/topic/$qntm), [nasdaq](/topic/nasdaq), [holidays](/topic/holidays), [rdnt](/topic/rdnt), [kucoin](/topic/kucoin), [combo](/topic/combo), [qubt](/topic/qubt), [pfe](/topic/pfe), [avgo](/topic/avgo), [cha](/topic/cha), [$entb](/topic/$entb), [$allo](/topic/$allo), [meta](/topic/meta), [iren](/topic/iren), [qqq](/topic/qqq), [png](/topic/png), [protocol](/topic/protocol), [decentralized](/topic/decentralized), [akro akero therapeutics inc](/topic/akro-akero-therapeutics-inc), [sei](/topic/sei), [gamma](/topic/gamma), [#foryoupage](/topic/#foryoupage), [$alny](/topic/$alny), [sterilite](/topic/sterilite), [sndl](/topic/sndl), [dnut](/topic/dnut), [corz](/topic/corz), [vrtx](/topic/vrtx), [zim](/topic/zim), [lulu](/topic/lulu), [oscr](/topic/oscr), [$cf](/topic/$cf), [bmw](/topic/bmw), [$tngx](/topic/$tngx), [$kros](/topic/$kros), [$lly](/topic/$lly), [$sgmt](/topic/$sgmt), [mrna](/topic/mrna), [dltr](/topic/dltr), [$veon](/topic/$veon), [exas](/topic/exas), [binance](/topic/binance), [coconut](/topic/coconut), [xcad](/topic/xcad), [ing](/topic/ing), [ego](/topic/ego), [aeva](/topic/aeva), [pew](/topic/pew), [stt](/topic/stt), [allk](/topic/allk), [agi](/topic/agi), [$schw](/topic/$schw), [$uuuu](/topic/$uuuu), [ter](/topic/ter), [$psnl](/topic/$psnl), [stockmarket](/topic/stockmarket), [pdsb](/topic/pdsb), [slm](/topic/slm), [volatility](/topic/volatility), [coins storage](/topic/coins-storage), [soun](/topic/soun), [empire](/topic/empire), [paris](/topic/paris), [spx](/topic/spx) ### Top Social Posts [#](/topic/akro/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "@badinvestor99 @Matthew_ABCD I am not interested in MASH now. And I understand FDA position. And I agree AKRO is small phase X and benefit will drop in phase X. But MDGl will likely acquire GLp1 to survive long term. That is the right thing to do" [@bioinvestor24](/creator/x/bioinvestor24) on [X](/post/tweet/1948845695630278889) 2025-07-25 20:39:56 UTC 3678 followers, XX engagements "@bioinvestor24 @Matthew_ABCD There is a reason the FDA chose two endpoints its NASH resolution and one stage reduction in fibrosis but you can email them and ask them to adjust that anyways Im not trying to convince you just letting you know your analysis is flawed. And $akro is not ITT so doesnt comp" [@badinvestor99](/creator/x/badinvestor99) on [X](/post/tweet/1948845134931529756) 2025-07-25 20:37:42 UTC XXX followers, XX engagements "@bioinvestor24 @Matthew_ABCD You realize XX% of NASH patients respond to GLP1. XX% of patients experience weight loss however. The two are mostly unrelated. Treatments follow steps its not one size fits all. $akro has the highest fibrosis benefit but the lowest weight loss" [@badinvestor99](/creator/x/badinvestor99) on [X](/post/tweet/1948840690261111132) 2025-07-25 20:20:02 UTC XXX followers, XX engagements "Akro Yoga Flow 🌪 #yoga #yogagirl #yogapractice" [@kalpsutralife](/creator/youtube/kalpsutralife) on [YouTube](/post/youtube-video/uO34SBR-5XE) 2025-07-25 19:58:42 UTC XXX followers, 1352 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Akro
AKRO stock sees high social media engagement amidst buyout rumors, but mixed trial results and shrinking community size raise concerns.
About Akro
Akero Therapeutics (AKRO) is a biotechnology company focused on developing treatments for metabolic dysfunction-associated steatohepatitis (MASH).
Insights #
- akro sentiment is up XXXXX% from the previous week.
Engagements: XXXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX -XX%
1 Month: XXXXXXXXX +33%
6 Months: XXXXXXXXXX -XX%
1 Year: XXXXXXXXXX -XXXX%
1-Year High: XXXXXXX on 2025-01-12
1-Year Low: XXX on 2025-07-26
| Social Network | X | TikTok | YouTube | News | |
|---|---|---|---|---|---|
| Engagements | XXXXXX | XXXXXX | XXXXXX | XXX | X |
Mentions: XXX #
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX +0.46%
1 Month: XXXXX +55%
6 Months: XXXXX -XX%
1 Year: XXXXXX -XX%
1-Year High: XXXXX on 2024-12-24
1-Year Low: XX on 2025-07-26
| Social Network | X | TikTok | YouTube | News | |
|---|---|---|---|---|---|
| Mentions | XX | XX | XXX | XX | X |
Creators: XXX #
Creators 24-Hour Chart Data
XXX unique social accounts have posts mentioning Akro in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XXX
1 Week: XXX -XXXX%
1 Month: XXXXX +89%
6 Months: XXXXX -XX%
1 Year: XXXXX +15%
1-Year High: XXX on 2024-12-24
1-Year Low: XX on 2025-07-26
The most influential creators that mention Akro in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @akro0059 | X | XXXXXX | X | XXXXX |
| @adelp | X | X | X | XXXXX |
| @fatmab.aymaz | X | XXXXX | X | XXXXX |
| @leniiolaichomi10 | X | XX | X | XXX |
| @Biobeats99 | X | XXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +13%
1 Month: XX% -X%
6 Months: XX% -X%
1 Year: XX% -XX%
1-Year High: XX% on 2024-09-14
1-Year Low: XX% on 2025-03-30
Most Supportive Themes
- Positive Sentiment and MASH Focus: (63%) Positive sentiment is high, with XX% of mentions being positive, and the company's focus on MASH treatment is generating interest.
- High Social Media Engagement: (35%) Mentions of AKRO are frequent across multiple social media platforms, with high engagement on TikTok and X.
Most Critical Themes
- Mixed Trial Results: (1%) Concerns about mixed results from the IMPACT trial of pemvidutide in MASH are being discussed.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXXX | XX% | XXXXX | XX% | XXX | X% |
| TikTok | XXXXX | XX% | XXXXX | XX% | XXX | X% |
| YouTube | XXXXX | X% | XXXXX | XX% | XXX | X% |
| XX | X% | XX | X% | XX | X% | |
| News | X | X% | X | X% | X | X% |
| Total | XXXXXX | XX% | XXXXXX | XX% | XXXXX | X% |
Top assets mentioned In the posts about Akro in the last XX hours
Akropolis (AKRO) Bitcoin Incognito (XBI) Akero Therapeutics, Inc. Common Stock (AKRO) Alnylam Pharmaceuticals, Inc. (ALNY) Californium (CF) Eli Lilly and Company (LLY) Charles Schwab Corporation (SCHW) Swap (XWP) Berry Global Group, Inc. (BERY) Akropolis (AKRO)
Top topics mentioned In the posts about Akro in the last XX hours
#fyp, fragrance, coins sports, vera, stocks technology, $abs, wts, alt, ola, rklb, $sndx, pltr, #viral, stocks, dawn, gme, par, coins music, roma, coins healthcare, $etnb, balance sheet, hims, whatsapp, $xbi, amgn, acquisition, rna, hood, nxt, tiktok, foryoupage, mbx, instagram, op, $glpg, $qntm, nasdaq, holidays, rdnt, kucoin, combo, qubt, pfe, avgo, cha, $entb, $allo, meta, iren, qqq, png, protocol, decentralized, akro akero therapeutics inc, sei, gamma, #foryoupage, $alny, sterilite, sndl, dnut, corz, vrtx, zim, lulu, oscr, $cf, bmw, $tngx, $kros, $lly, $sgmt, mrna, dltr, $veon, exas, binance, coconut, xcad, ing, ego, aeva, pew, stt, allk, agi, $schw, $uuuu, ter, $psnl, stockmarket, pdsb, slm, volatility, coins storage, soun, empire, paris, spx
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@badinvestor99 @Matthew_ABCD I am not interested in MASH now. And I understand FDA position. And I agree AKRO is small phase X and benefit will drop in phase X. But MDGl will likely acquire GLp1 to survive long term. That is the right thing to do"
@bioinvestor24 on X 2025-07-25 20:39:56 UTC 3678 followers, XX engagements
"@bioinvestor24 @Matthew_ABCD There is a reason the FDA chose two endpoints its NASH resolution and one stage reduction in fibrosis but you can email them and ask them to adjust that anyways Im not trying to convince you just letting you know your analysis is flawed. And $akro is not ITT so doesnt comp"
@badinvestor99 on X 2025-07-25 20:37:42 UTC XXX followers, XX engagements
"@bioinvestor24 @Matthew_ABCD You realize XX% of NASH patients respond to GLP1. XX% of patients experience weight loss however. The two are mostly unrelated. Treatments follow steps its not one size fits all. $akro has the highest fibrosis benefit but the lowest weight loss"
@badinvestor99 on X 2025-07-25 20:20:02 UTC XXX followers, XX engagements
"Akro Yoga Flow 🌪 #yoga #yogagirl #yogapractice"
@kalpsutralife on YouTube 2025-07-25 19:58:42 UTC XXX followers, 1352 engagements